ScholarIQanswers from OpenAlex

Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia

PaperCitations, authors & open-access status

Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia have?

ScholarIQcitation count

Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia has 92 citations in the OpenAlex counts ScholarIQ stores.

When was Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia published?

ScholarIQyear

Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia has 2023 year in the ScholarIQ index.

What is the open-access status of Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia?

ScholarIQoa status

Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia has gold oa status in the ScholarIQ index.

What is the DOI of Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia?

ScholarIQdoi

The DOI for Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia is on the source record.

What is the PMID of Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia?

ScholarIQpmid

The PMID for Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia is on the source record.

What is the OpenAlex record for Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia?

ScholarIQopenalex

The OpenAlex for Plasma GFAP in Parkinson’s disease with cognitive impairment and its potential to predict conversion to dementia is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial